VOYA Investment Management
PTCT icon

VOYA Investment Management’s PTC Therapeutics PTCT Stock Holding History

VOYA Investment Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44M Buy
539,319
+196,682
+57% +$14.2M 0.04% 338
2026
Q1 		$23.3M Buy
342,637
+3,491
+1% +$247K 0.02% 438
2025
Q4 		$25.8M Buy
339,146
+54,255
+19% +$3.94M 0.03% 452
2025
Q3 		$17.5M Buy
284,891
+24,399
+9% +$1.27M 0.02% 531
2025
Q2 		$12.7M Buy
260,492
+148,361
+132% +$7.04M 0.01% 664
2025
Q1 		$5.71M Sell
112,131
-80,350
-42% -$4.01M 0.01% 916
2024
Q4 		$8.69M Buy
192,481
+113,633
+144% +$4.86M 0.01% 785
2024
Q3 		$2.93M Buy
78,848
+38,556
+96% +$1.29M ﹤0.01% 1211
2024
Q2 		$1.23M Buy
40,292
+16,036
+66% +$519K ﹤0.01% 1517
2024
Q1 		$706K Sell
24,256
-4,431
-15% -$124K ﹤0.01% 1826
2023
Q4 		$791K Sell
28,687
-13,684
-32% -$313K ﹤0.01% 1819
2023
Q3 		$950K Sell
42,371
-115
-0.3% -$4.28K ﹤0.01% 1664
2023
Q2 		$1.73M Buy
42,486
+14,232
+50% +$696K ﹤0.01% 1405
2023
Q1 		$1.37M Sell
28,254
-143,697
-84% -$6.57M ﹤0.01% 1507
2022
Q4 		$6.56M Buy
171,951
+52,116
+43% +$2.17M 0.01% 868
2022
Q3 		$6.02M Buy
119,835
+39,979
+50% +$1.96M 0.01% 883
2022
Q2 		$3.2M Sell
79,856
-28,157
-26% -$987K 0.01% 919
2022
Q1 		$4.03M Buy
108,013
+80,612
+294% +$3.11M 0.01% 904
2021
Q4 		$1.09M Buy
27,401
+353
+1% +$13.5K ﹤0.01% 1491
2021
Q3 		$1.01M Hold
27,048
– – ﹤0.01% 1569
2021
Q2 		$1.14M Sell
27,048
-78,834
-74% -$3.38M ﹤0.01% 1545
2021
Q1 		$5.01M Sell
105,882
-13,448
-11% -$799K 0.01% 838
2020
Q4 		$7.28M Sell
119,330
-130,797
-52% -$7.71M 0.01% 691
2020
Q3 		$11.7M Buy
250,127
+2,948
+1% +$145K 0.03% 482
2020
Q2 		$12.5M Sell
247,179
-51,843
-17% -$2.55M 0.03% 448
2020
Q1 		$13.3M Sell
299,022
-4,225
-1% -$213K 0.04% 395
2019
Q4 		$14.6M Buy
303,247
+281,065
+1,267% +$11.9M 0.03% 484
2019
Q3 		$750K Hold
22,182
– – ﹤0.01% 1502
2019
Q2 		$998K Buy
22,182
+2,073
+10% +$81.9K ﹤0.01% 1363
2019
Q1 		$757K Buy
20,109
+1,411
+8% +$47.4K ﹤0.01% 1524
2018
Q4 		$642K Buy
18,698
+779
+4% +$28K ﹤0.01% 1569
2018
Q3 		$842K Hold
17,919
– – ﹤0.01% 1508
2018
Q2 		$604K Sell
17,919
-296
-2% -$9.23K ﹤0.01% 1682
2018
Q1 		$493K Hold
18,215
– – ﹤0.01% 1810
2017
Q4 		$304K Hold
18,215
– – ﹤0.01% 2131
2017
Q3 		$364K Buy
18,215
+1,756
+11% +$34.4K ﹤0.01% 2062
2017
Q2 		$302K Buy
16,459
+1,866
+13% +$25.1K ﹤0.01% 2156
2017
Q1 		$144K Hold
14,593
– – ﹤0.01% 2371
2016
Q4 		$159K Hold
14,593
– – ﹤0.01% 2370
2016
Q3 		$204K Hold
14,593
– – ﹤0.01% 2277
2016
Q2 		$102K Hold
14,593
– – ﹤0.01% 2468
2016
Q1 		$94K Hold
14,593
– – ﹤0.01% 2412
2015
Q4 		$473K Hold
14,593
– – ﹤0.01% 1756
2015
Q3 		$390K Sell
14,593
-1,995
-12% -$85.3K ﹤0.01% 1881
2015
Q2 		$798K Buy
16,588
+3,618
+28% +$211K ﹤0.01% 1598
2015
Q1 		$789K Hold
12,970
– – ﹤0.01% 1614
2014
Q4 		$671K Hold
12,970
– – ﹤0.01% 1721
2014
Q3 		$571K Hold
12,970
– – ﹤0.01% 1812
2014
Q2 		$339K Buy
+12,970
New +$278K ﹤0.01% 2273

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

VOYA Investment Management's PTCT Position: Q2 2026 in Review

VOYA Investment Management increased its PTC Therapeutics (PTCT) stake by 57% in Q2 2026, buying an estimated $14.2M and bringing the position to 539,319 shares worth $44M. The position accounts for 0.04% of the portfolio, ranked #338.

VOYA Investment Management first reported a position in PTCT in Q2 2014 and has held it in 49 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • VOYA Investment Management held 539,319 shares of PTC Therapeutics worth $44M as of Q2 2026.
  • VOYA Investment Management bought 196,682 PTC Therapeutics shares in Q2 2026, an estimated $14.2M.
  • PTC Therapeutics made up 0.04% of VOYA Investment Management's portfolio in Q2 2026, its #338 holding.
  • VOYA Investment Management first reported a position in PTC Therapeutics in Q2 2014 and has held it in 49 quarters since.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.